Breaking NewsDose daily PCI Unveils NEP-Aligned B.Pharm Curriculum for 2026–27 with Focus on AI and Industry Readiness By: Dose Daily News Bureau Date: April 17, 2026 Share post: FacebookXPinterestWhatsApp Tags2026-27BPHARM Previous articleFDA Grants Priority Review to Daiichi Sankyo–Merck’s First-in-Class Lung Cancer ADCNext articlePharmacy Students’ Initiative at Hridaypur, Barasat: Bringing Healthcare and Humanity to the Underserved Dose Daily News Bureauhttps://dosedailynews.com/ LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. I want inI've read and accept the Privacy Policy. Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research admin - July 24, 2026 Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment Breaking News CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation Breaking News EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market Breaking News CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017 Breaking News OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets Breaking News Related articles Breaking News Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference... Breaking News Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment Emcure Pharmaceuticals Ltd announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs... Breaking News CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology... Breaking News EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise, announced the launch of Hospital...